We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
N4 Pharma Plc | LSE:N4P | London | Ordinary Share | GB00BYW8QM32 | ORD 0.4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.825 | 0.80 | 0.85 | 0.85 | 0.80 | 0.80 | 3,285,001 | 15:54:08 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Drug & Proprietary Stores | 0 | -1.03M | -0.0057 | -1.44 | 1.48M |
Date | Subject | Author | Discuss |
---|---|---|---|
13/8/2018 11:49 | LOL. I'll happily donate to your worthy cause if we hit one of Hugh's price targets!hughwilson - 02 Feb 2018If Nuvec becomes the industry standard then even £4.00 would be conservative but one step at a time. hughwilson - 13 Mar 2018 - 16:09:17 - 2808 of 3884Eddie, I have always said £2 as a starter but once revenues start to really kick in it could go above £4. hughwilson - 24 May 2018 - 16:12:35scotty666,On twitter I suggested that 18.5p was a good time to buy as the share price had been pushed down to an artificially low level by a connected person selling. | dplewis1 | |
13/8/2018 11:22 | hugh? hugh? Where have you suddenly disappeared to? | nobbygnome | |
13/8/2018 11:03 | Ok let's see who is correct about fund raising by Christmas. I predict there will be a fund raising before Christmas. If there isn't, I will give £100 to NRAS my favourite charity for whom I give free presentations to patients and £100 to a charity of your choice. If there is a fundraising, you do the same. Deal? | nobbygnome | |
13/8/2018 10:48 | BTW To spare everyone else, I am happy to stop this stupid spat, if you stop attacking me personally. Let's talk about N4P which is a very interesting subject. | nobbygnome | |
13/8/2018 10:44 | LOL You have so much to learn as a naive investor. I will explain it simply for you. The vast majority of my portfolio is held long term for huge gains. However, in all stocks I trade round the edges. Also occasionally I momentum trade as I did on N4P and made a good sum. However, I rapidly realised that there were fundamental problems with the company particularly the sildenafil reformulation so decided to sell out.....which strangely was the correct decision. Meanwhile you are left holding at a massive loss because of your naivety. Watch and learn hugh.... | nobbygnome | |
13/8/2018 10:36 | Nobbygnome - 24 Jul 2018 - 20:09:24 - 334 of 644 N4 Pharma - N4P As always I will be trading as well as holding some for the long term. With N4P I had decided there was no real future and was in the process of selling out. However, I was too greedy and was left with 10k, which I still have. C'est la vie.... Nobby | hughwilson | |
13/8/2018 10:30 | Misinformation yet again, professional investor not trader! Is your real name Donald Trump; you are so good at fake news! | nobbygnome | |
13/8/2018 10:29 | That is your ultimate naive statement. So do you really think beloved Nigel would say 'yes we are planning to do a fund raising next month'. LOL talk about naive. There will be a pregnant pause ahead of a fund raising but I would guess in about 2-3 months, one will appear. I am not quite sure how I can apologise for something in the future.....but you can certainly apologise for something in the past! | nobbygnome | |
13/8/2018 10:26 | "I am now a very successful professional investor" Finally Nobby has admitted that he is a professional trader. Everything he says can be taken with a pinch of salt because it will be the result of his agenda. As for a professional investor, I think that you have already proved that you are not an investor at all and certainly not long-term, you are a trader and a pump & dump merchant and no more. | hughwilson | |
13/8/2018 10:19 | Nobbo, any apology from you in saying that the next thing we will see is a cash call when I have asked Nigel about this and it is totally false- NO Any apology from you in saying that the company is in trouble when in fact it is well funded- NO. Any apology from you in saying that the company had not budgeted for a retrial when it has-No. So I could go on. Nothing but lies and misinformation from someone who claims to know everything. | hughwilson | |
13/8/2018 10:05 | Oh and still no apology for your generic statement lies... | nobbygnome | |
13/8/2018 10:03 | LOL talk about personal attacks! You are correct in as much as I might buy in the next fund raising at 5p..... Now that is probably a stupid thing to write because the sad person that you are, you will quote it in every other post hence forward. However, I am going to leave it in because by doing that you will prove what a sad person you are! I will continue to post because strangely this is a free country and as an informed ex Pharma employee, I feel the urge to counter your constant misinformation. And I am now a very successful professional investor and you should watch and learn 😜! The only way to overcome your naivety is to learn from experienced investors. Nobby | nobbygnome | |
13/8/2018 09:20 | Nobbo, you are a cheap two-bit trader and no more. You have £700 of N4 and even that is because you failed to sell them all and yet you spend all day here trying to de ramp the company and anyone who is positive. I would have more respect for you if you were to admit that you wanted the price lower so that you could load up. If you were that negative on the company then you would sell your pittance of a holding and move on but as a trader you seek to load up again which means that you are not quite so negative about the company's future as you currently make out. Must admit that I was really disappointed by the quality of your ramping on other stocks, I would have expected better of you. | hughwilson | |
12/8/2018 19:05 | Oh and please can you apologise for your incorrect generics statement? | nobbygnome | |
12/8/2018 19:00 | Oh dear you are becoming obsessed with my posts hugh! And as usual you are misleading everybody, I am a LTH in most cases who trades around the edges. Plus I call it right on biotechs regularly unlike you......but hey, as usual don't let the truth get in the way of a good story. And that statement sums you up! Nobby | nobbygnome | |
12/8/2018 18:32 | Nobbo, having reviewed some of your posts on other shares, please don`t call me a ramper ever again.Your ramps are cheap and are on a par with your deramps here. I now understand that you are just a trader and no more than that. | hughwilson | |
12/8/2018 11:23 | "flagship first reformulation" agree featherby .. I said that some time ago, the market has slammed the share price because this was their first reformulation product and fair to say the one they surely were then most confident about. So announcing a fail before half way has significantly impacted confidence in the company. ODR | onedayrodders | |
12/8/2018 09:01 | Jimbo yes he is quite good at responding (I even got an email not long after the end of the England Croatia game) but is obviously careful with what he says. My view is that he's made a bit of a rod for his own back by responding to multiple PIs as you then get a "Nigel said this.." and "Nigel said that..", and subjective interpretations of the same words. That does seem to be his style though so that's fair enough, I'd rather hear something than getting blanked. | dplewis1 | |
12/8/2018 08:57 | If I can be corrected and learn something when informed of my mistakes I’m very happy to listen. As I said, very little Pharma knowledge. | featherby81 | |
12/8/2018 08:54 | I think that is a big 'if'....but at least you are not stating it as fact like a certain other misleading poster! | nobbygnome | |
12/8/2018 08:52 | Good morning Jimbobaroony, not new to investing nor Advfn but never had enough cash invested into a specific company to justify posting. N4P is my largest holding currently and look to increase once we have some feedback from the collaboration. The trial results were disappointing but I was pre advised to be prepared for trials not meeting the target and further amendments needing. I did originally join N4 for Sidenafil and not with a long term strategy but my investment research source quickly stated I needed to concentrate on the upcoming drug delivery technology. I’m ready for the barrage of criticism by the way for this next sentence..If Nuvec continues to prove that it can sustain the particle release delay without loosing its payload in all situations with zero waste once completed, surely we could be looking at a once in a lifetime investment???. | featherby81 | |
12/8/2018 08:50 | >> featherby I am not sure how cash isn't the issue. A reformulation and another trial is an unplanned expense plus any revenues from the drug are now much further away. That is bound to affect their financial forecasts and so it appears to me is likely to cause a cash problem. If they are negotiating deals on Nuvec, they cannot in any way be restricted by cash because then you are negotiating with one hand tied behind your back. That is why I think a fund raising is highly likely in the near future especially since they got a new broker out of the blue. | nobbygnome |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions